|
Re: RVX FILES ANNUAL INFO FORM
|
7
|
Resverlogix Corp.
|
Jul 27, 2015 11:24PM
|
|
Re: Rodman and Renshaw Conf
|
7
|
Resverlogix Corp.
|
Sep 13, 2016 04:27PM
|
|
Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
7
|
Resverlogix Corp.
|
Jun 22, 2020 07:26AM
|
|
ESC 2018 Symposium and Presentation August 25-29, Munich
|
7
|
Resverlogix Corp.
|
Aug 14, 2018 01:55PM
|
|
Re: Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
7
|
Resverlogix Corp.
|
Jul 29, 2020 09:57AM
|
|
Re: so what happens if dm fumbles the ball??
|
7
|
Resverlogix Corp.
|
Jul 13, 2020 10:05AM
|
|
RVX in the next 5 weeks
|
7
|
Resverlogix Corp.
|
Aug 12, 2016 10:47AM
|
|
BD-2 selective bromodomain inhibitors
|
7
|
Zenith Epigenetics
|
Sep 15, 2018 10:57AM
|
|
Re: If anyone still cares about science...
|
7
|
Resverlogix Corp.
|
Oct 09, 2020 05:15PM
|
|
Re: ZHCLF trading
|
7
|
Zenith Epigenetics
|
Feb 08, 2021 12:51PM
|
|
Re: TLD Confidence
|
7
|
Resverlogix Corp.
|
Aug 26, 2019 07:28AM
|
|
Re: Why investing in RVX is hard right now.....
|
7
|
Resverlogix Corp.
|
Jun 18, 2015 11:16AM
|
|
Re: PNAS - jbuffet
|
7
|
Resverlogix Corp.
|
Jan 02, 2021 05:50PM
|
|
American Diabetes Association 2017 Abstract
|
7
|
Resverlogix Corp.
|
Jun 03, 2017 05:06PM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
7
|
Resverlogix Corp.
|
Jun 02, 2019 08:37AM
|
|
Zacks SCR Report 3/27/2017
|
7
|
Resverlogix Corp.
|
Mar 27, 2017 06:10PM
|
|
Re: Comments on the AGM
|
7
|
Resverlogix Corp.
|
Nov 08, 2019 01:56PM
|
|
Re: Resverlogix H2 2018 events
|
7
|
Resverlogix Corp.
|
Aug 28, 2018 04:51PM
|
|
Re: BETonMACE Enrollment
|
7
|
Resverlogix Corp.
|
Mar 24, 2017 03:15PM
|
|
Biogen/Eisai Scrap Aducanumab
|
7
|
Resverlogix Corp.
|
Mar 21, 2019 08:32AM
|
